UPLOAD Filing
FG Nexus Inc.
Date: Aug. 12, 2025 · CIK: 0001591890 · Accession: 0000000000-25-008452
AI Filing Summary & Sentiment
File numbers found in text: 001-36366
Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
August 12, 2025
D. Kyle Cerminara
Chief Executive Officer
Fundamental Global Inc.
6408 Bannington Road
Charlotte, NC 28226
Re: Fundamental Global Inc.
Preliminary Information Statement on Schedule 14C
Filed July 30, 2025
File No. 001-36366
Dear D. Kyle Cerminara:
We have reviewed your filing and have the following comments.
Please respond to this letter within ten business days by providing the
requested
information or advise us as soon as possible when you will respond. If you do
not believe a
comment applies to your facts and circumstances, please tell us why in your
response.
After reviewing your response to this letter, we may have additional
comments.
Preliminary Information Statement on Schedule 14C
General
1. We note your disclosure on page 1 and elsewhere that the contingent
value rights
("CVRs") will be distributed to existing shareholders in connection with
the transfer
of assets to the CVR Trust. Please confirm, and revise your disclosure
to clearly state
that shareholders will not provide any consideration to receive the
CVRs.
2. Staff Legal Bulletin No. 4 indicates that, when a spun-off entity will
not be a reporting
company, shareholders and the market must receive "adequate information"
about the
spun-off entity in order to fit into the safe harbor to avoid
registration. Please tell us
whether you plan to provide this information and how you plan to
communicate it to
the CVR holders, if you do not intend to register the transaction.
3. Please revise your disclosure to provide additional information
regarding the assets to
be transferred to the CVR Trust. Clarify the party or parties that will
manage the
liquidation and monetization of the assets in the CVR trust and any
compensation that
those parties will receive for their services, including how those
payments may impact
the value of the assets in the CVR trust available to shareholders.
Also, clarify the
August 12, 2025
Page 2
strategy and expected timing for monetizing the assets and the source of
any
anticipated distributions to CVR holders.
4. Please expand your disclosure to more clearly describe the legacy assets
you will
retain following the transfer to the CVR Trust, including the nature and
book value
of the retained assets.
5. Please revise your disclosure to quantify the potential dilutive impact
to current
shareholders from all recent and pending securities issuances, including
pre-funded
warrants, on a fully diluted basis.
We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
of action by the staff.
Please contact Robert Arzonetti at 202-551-8819 or Christian Windsor at
202-551-
3419 with any other questions.
Sincerely,
Division of
Corporation Finance
Office of Finance
cc: Jim Prestiano
</TEXT>
</DOCUMENT>